Rocket One Inc Dossier - Source-backed chat

Rocket One Inc

RKTONASDAQ

SectorHealth Care

IndustryPharmaceuticals

Beta (adjusted)0.96

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $0.69Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $17.2M

Shares Outstanding 24.9M diluted

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Rocket One Inc. (formerly Hoth Therapeutics, Inc.) has undergone a dramatic strategic pivot from biotechnology to advanced AI computing, defense infrastructure, and space-enabling technologies. While the rebrand and shift to high-growth themes like orbital AI chips and spintronic computing have generated significant retail momentum and temporarily restored Nasdaq compliance, the company remains in an extremely early, pre-revenue development stage. With substantial capital requirements, unproven technology, and a history of heavy cash burn, the stock is highly speculative. A Hold recommendation is advised until the company demonstrates tangible progress in fabricating its licensed technologies and securing commercial or government contracts.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets2 analysts

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.4020%

The licensed semiconductor technologies fail to achieve technical feasibility or commercial viability. The company is unable to raise the substantial additional capital required for fabrication and testing, leading to severe dilution or distress. The stock falls back below the $1.00 threshold, risking Nasdaq delisting.

Base CaseCentral scenario

$1.0055%

Rocket One continues its R&D efforts and slowly advances its orbital computing platforms. The company relies on dilutive equity financing to fund its high cash burn, while its legacy biotech pipeline (advanced under a subsidiary) provides limited near-term value. The stock trades in a volatile range reflecting its speculative nature.

Bull CaseUpside scenario

$5.0025%

The company successfully validates its nanomagnetic matrix multiplier architecture and spintronic memory technology in space environments (e.g., through NASA's MISSE program). Strategic collaborations, such as the partnership with Placeve Inc., accelerate hardware integration and lead to high-margin defense or aerospace contracts, driving rapid valuation expansion.

Scenarios reflect our research view at the research date.

Key Investment Merits

Exposure to high-growth secular themes including space economy, defense tech, and AI hardware acceleration.
Exclusive license agreements for novel spintronic and nanomagnetic computing architectures designed to address power and memory bottlenecks.
Strategic advisory support from high-profile experts, including former NASA astronaut Shane Kimbrough and Dr. Supriyo Bandyopadhyay.

Key Investment Risks

Extremely early-stage technologies that have not been fabricated as integrated devices or validated in space.
High cash burn rate relative to current cash reserves, indicating a short runway and high risk of dilutive equity financing.
Intense competition from established, well-capitalized semiconductor and aerospace giants.

Thesis Invalidation Triggers

Loss of exclusive license rights due to failure to meet diligence milestones under the Virginia Commonwealth University agreements.
Severe delays or negative results from the evaluation of Placeve's processor technology under NASA's MISSE program.
Rapid depletion of cash reserves without securing non-dilutive funding or strategic investments.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.